Cost-effectiveness of SelectMDx for prostate cancer in four European countries: a comparative modeling study

被引：0

作者：

Tim M. Govers

Daphne Hessels

Virginie Vlaeminck-Guillem

Bernd J. Schmitz-Dräger

Christian G. Stief

Claudio Martinez-Ballesteros

Matteo Ferro

Angel Borque-Fernando

Jose Rubio-Briones

J. P. Michiel Sedelaar

Wim van Criekinge

Jack A. Schalken

机构：

[1] MedValue,Medical Unit of Molecular Oncology and Transfer, Department of Biochemistry and Molecular Biology

[2] MDxHealth BV,Cancer Research Centre of Lyon, U1052 INSERM, CNRS 5286, Léon Bérard Centre

[3] University Hospital of Lyon-Sud,BSD: Urologie24, Nuremberg and Dept. of Urology

[4] Hospices Civils of Lyon,Department of Urology

[5] Lyon I University,Urology department

[6] Friedrich-Alexander University,Division of Urology

[7] Ludwig Maximilians-Universität München,Department of Urology

[8] Hospital Universitario Puerta de Hierro Majadahonda,Department of Urology

[9] European Institute of Oncology,Department of Urology

[10] Hospital Universitatio Miguel Servet,Department of Mathematical Modelling, Statistics and Bioinformatics

[11] IIS-Aragón,Department of Urology

[12] Fundación instituto Valenciano,undefined

[13] de oncología,undefined

[14] Radboudumc,undefined

[15] Ghent University,undefined

[16] Radboudumc,undefined

来源：

Prostate Cancer and Prostatic Diseases | 2019年 / 22卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：101 / 109

页数：8

共 50 条

[1] Cost-effectiveness of SelectMDx for prostate cancer in four European countries: a comparative modeling study
Govers, Tim M.
Hessels, Daphne
Vlaeminck-Guillem, Virginie
Schmitz-Draeger, Bernd J.
Stief, Christian G.
Martinez-Ballesteros, Claudio
Ferro, Matteo
Borque-Fernando, Angel
Rubio-Briones, Jose
Sedelaarll, J. P. Michiel
van Criekinge, Wim
Schalken, Jack A.
PROSTATE CANCER AND PROSTATIC DISEASES, 2019, 22 (01) : 101 - 109
[2] COST-EFFECTIVENESS OF SELECTMDX FOR PROSTATE CANCER IN FOUR EUROPEAN COUNTRIES: A MODELLING STUDY
Hessels, Daphne
Govers, Tim
Van Criekinge, Wim
Vlaeminck-Guillem, Virginie
Schmitz-drager, Bernd
Stief, Christian
Schalken, Jack
JOURNAL OF UROLOGY, 2018, 199 (04): : E614 - E615
[3] Comparative cost-effectiveness analysis of oral triptan therapy for migraine in four European countries
Hens, Manuel
Villaverde-Hueso, Ana
Alonso, Veronica
Abaitua, Ignacio
Posada de la Paz, Manuel
EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2014, 15 (04): : 433 - 437
[4] Comparative cost-effectiveness analysis of oral triptan therapy for migraine in four European countries
Manuel Hens
Ana Villaverde-Hueso
Veronica Alonso
Ignacio Abaitua
Manuel Posada de la Paz
The European Journal of Health Economics, 2014, 15 : 433 - 437
[5] Cost-effectiveness of physical activity interventions in four European countries
Lafranconi, A.
Cesana, G.
EUROPEAN JOURNAL OF PUBLIC HEALTH, 2017, 27
[6] COST-EFFECTIVENESS OF PROSTATE CANCER SCREENING BASED ON THE EUROPEAN RANDOMISED STUDY OF SCREENING FOR PROSTATE CANCER
Heijnsdijk, Eveline
Wever, Elisabeth
de Koning, Harry
JOURNAL OF UROLOGY, 2012, 187 (04): : E491 - E491
[7] COMPARATIVE STUDY OF THE COST-EFFECTIVENESS OF TRASTUZUMAB IN THE TREATMENT OF BREAST CANCER IN DIFFERENT COUNTRIES
Rabbani, S.
Ardam, A.
Salamzadeh, J.
VALUE IN HEALTH, 2013, 16 (07) : A411 - A411
[8] Considerations for modeling the cost-effectiveness of preventative prostate cancer treatments
Bell, C. F.
McDade, C. L.
Black, L.
Earnshaw, S. R.
Kattan, M. W.
VALUE IN HEALTH, 2008, 11 (03) : A61 - A61
[9] MODELING THE COST-EFFECTIVENESS OF PROSTATE CANCER TREATMENT WITH PARTICLE THERAPY
Peeters, A.
Joore, M. A.
Pijls-Johannesma, M.
De Ruysscher, D.
Dekker, A. L.
Grutters, J. P.
Reimoser, S.
Severens, J. L.
Lambin, P.
VALUE IN HEALTH, 2008, 11 (06) : A473 - A473
[10] Transportability of Comparative Effectiveness and Cost-Effectiveness between Countries
Briggs, Andrew
VALUE IN HEALTH, 2010, 13 : S22 - S25

← 1 2 3 4 5 →